Healthcare -
Biotechnology - NASDAQ - US
$ 12.05
-14.9 %
$ 178 M
Market Cap
-0.54
P/E
LYEL - CASH FROM OPERATIONS
Cash from Operations LYEL - Lyell Immunopharma, Inc.
-162 M
LAST VALUE
2.13%
2 YEAR CAGR
-38.60%
5 YEAR CAGR
0.00%
10 YEAR CAGR